BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32271415)

  • 1. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.
    Wu JZ; Jiang N; Lin JM; Liu X
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2977-2985. PubMed ID: 32271415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
    Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MT1JP inhibits the malignant progression of hepatocellular carcinoma through regulating AKT.
    Wu JH; Xu K; Liu JH; Du LL; Li XS; Su YM; Liu JC
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6647-6656. PubMed ID: 32633354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
    Liu FH; Cui YP; He YK; Shu RH
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.
    Liang Y; Luo H; Zhang H; Dong Y; Bao Y
    Cancer Biother Radiopharm; 2018 Nov; 33(9):380-386. PubMed ID: 30235011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway.
    Li BH; Wang Y; Wang CY; Zhao MJ; Deng T; Ren XQ
    Med Sci Monit; 2018 Nov; 24():8105-8114. PubMed ID: 30418964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.
    Wu JH; Tian XY; An QM; Guan XY; Hao CY
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1645-1652. PubMed ID: 29630107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway.
    He Y; Liu X
    Biomed Pharmacother; 2015 Dec; 76():141-6. PubMed ID: 26653561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA.
    Tuo H; Liu R; Wang Y; Yang W; Liu Q
    World J Surg Oncol; 2023 Mar; 21(1):111. PubMed ID: 36973749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
    Li H; Yuan R; Wang H; Li C; Wei J
    J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124.
    Zhang S; Liu Y; Liu Z; Zhang Y; Chen G; Li K; Tang K
    J BUON; 2019; 24(6):2402-2410. PubMed ID: 31983112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
    Li JZ; Li J; Liu BZ
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
    Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1.
    Wei YY; Ren TL
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.